{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:31:09Z","timestamp":1784543469523,"version":"3.55.0"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T00:00:00Z","timestamp":1651536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Deficiency of adenosine deaminase type 2 (DADA2) was first described in 2014 as a monogenic cause of polyartertitis nodosa (PAN), early onset lacunar stroke and livedo reticularis. The clinical phenotype of DADA2 is, however, very broad and may involve several organ systems. Apart from vasculitis, children may present with i) Hematological manifestations (ii) Lymphoproliferation and iii) Immunodeficiencies. Patients with DADA2 can have variable patterns of cytopenias and bone marrow failure syndromes. Patients with DADA2 who have predominant haematological manifestations are associated with ADA2 gene variants that result in minimal or no residual ADA2 activity. Lymphoproliferation in patients with DADA2 may range from benign lymphoid hyperplasia to lymphoreticular malignancies. Patients may present with generalized lymphadenopathy, splenomegaly, autoimmune lymphoproliferative syndrome (ALPS) like phenotype, Hodgkin lymphoma, T-cell large granular lymphocytic infiltration of bone marrow and multicentric Castleman disease. Immunodeficiencies associated with DADA are usually mild. Affected patients have variable hypogammaglobulinemia, decrease in B cells, low natural killer cells, common variable immunodeficiency and rarely T cell immunodeficiency. To conclude, DADA2 has an extremely variable phenotype and needs to be considered as a differential diagnosis in diverse clinical conditions. In this review, we describe the evolving clinical phenotypes of DADA2 with a special focus on haematological and immunological manifestations.<\/jats:p>","DOI":"10.3389\/fimmu.2022.869570","type":"journal-article","created":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T05:48:32Z","timestamp":1651556912000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Deficiency of Human Adenosine Deaminase Type 2 \u2013 A Diagnostic Conundrum for the Hematologist"],"prefix":"10.3389","volume":"13","author":[{"given":"Rakesh Kumar","family":"Pilania","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaqib Zaffar","family":"Banday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saniya","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajni","family":"Kumrah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibhu","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathish","family":"Loganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manpreet","family":"Dhaliwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur Kumar","family":"Jindal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pandiarajan","family":"Vignesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepti","family":"Suri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Rawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surjit","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1307361","article-title":"Early-Onset Stroke and Vasculopathy Associated With Mutations in ADA2","volume":"370","author":"Zhou","year":"2014","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1307362","article-title":"Mutant Adenosine Deaminase 2 in a Polyarteritis Nodosa Vasculopathy","volume":"370","author":"Navon Elkan","year":"2014","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/imr.12722","article-title":"Human Adenosine Deaminase 2 Deficiency: A Multi-Faceted Inborn Error of Immunity","volume":"287","author":"Moens","year":"2019","journal-title":"Immunol Rev"},{"key":"B4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/eji.200425738","article-title":"New Insights Into Adenosine-Receptor-Mediated Immunosuppression and the Role of Adenosine in Causing the Immunodeficiency Associated With Adenosine Deaminase Deficiency","volume":"35","author":"Hershfield","year":"2005","journal-title":"Eur J Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200738094","article-title":"Enhanced B-Cell Activation Mediated by TLR4 and BCR Crosstalk","volume":"38","author":"Minguet","year":"2008","journal-title":"Eur J Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206184","article-title":"Adenosine Suppresses Activation of Nuclear Factor-KappaB Selectively Induced by Tumor Necrosis Factor in Different Cell Types","volume":"22","author":"Majumdar","year":"2003","journal-title":"Oncogene"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1109764","article-title":"Human Adenosine Deaminase 2 Induces Differentiation of Monocytes Into Macrophages and Stimulates Proliferation of T Helper Cells and Macrophages","volume":"88","author":"Zavialov","year":"2010","journal-title":"J Leukoc Biol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1515\/BC.2006.042","article-title":"Human Plasma Adenosine Deaminase 2 Is Secreted by Activated Monocytes","volume":"387","author":"Iwaki-Egawa","year":"2006","journal-title":"Biol Chem"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20050683","article-title":"Human ADA2 Belongs to a New Family of Growth Factors With Adenosine Deaminase Activity","volume":"391","author":"Zavialov","year":"2005","journal-title":"Biochem J"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-016-2357-0","article-title":"Human Adenosine Deaminases ADA1 and ADA2 Bind to Different Subsets of Immune Cells","volume":"74","author":"Kaljas","year":"2017","journal-title":"Cell Mol Life Sci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrrheum.2014.158","article-title":"New Players Driving Inflammation in Monogenic Autoinflammatory Diseases","volume":"11","author":"Martinon","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.01.018","article-title":"Detailed Analysis of Japanese Patients With Adenosine Deaminase 2 Deficiency Reveals Characteristic Elevation of Type II Interferon Signature and STAT1 Hyperactivation","volume":"148","author":"Nihira","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.3HI0220-119RR","article-title":"Analysis of Deficiency of Adenosine Deaminase 2 Pathogenesis Based on Single-Cell RNA Sequencing of Monocytes","volume":"110","author":"Watanabe","year":"2021","journal-title":"J Leukoc Biol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210802","article-title":"ADA2 Deficiency (DADA2) as an Unrecognised Cause of Early Onset Polyarteritis Nodosa and Stroke: A Multicentre National Study","volume":"76","author":"Caorsi","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/BF01115116","article-title":"Formation and Degradation of Deoxyadenosine Nucleotides in Inherited Adenosine Deaminase Deficiency","volume":"2","author":"Simmonds","year":"1982","journal-title":"Biosci Rep"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/art.39699","article-title":"Deficiency of Adenosine Deaminase Type 2: A Description of Phenotype and Genotype in Fifteen Cases","volume":"68","author":"Nanthapisal","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-018-0525-8","article-title":"Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment","volume":"38","author":"Meyts","year":"2018","journal-title":"J Clin Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.jaci.2018.01.012","article-title":"ADA2 Deficiency: Clonal Lymphoproliferation in a Subset of Patients","volume":"141","author":"Trotta","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-021-05711-w","article-title":"Expanding Spectrum of DADA2: A Review of Phenotypes, Genetics, Pathogenesis and Treatment","volume":"40","author":"Pinto","year":"2021","journal-title":"Clin Rheumatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-016-0245-x","article-title":"Deficiency of Adenosine Deaminase 2 Causes Antibody Deficiency","volume":"36","author":"Schepp","year":"2016","journal-title":"J Clin Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/art.40147","article-title":"Screening of 181 Patients With Antibody Deficiency for Deficiency of Adenosine Deaminase 2 Sheds New Light on the Disease in Adulthood","volume":"69","author":"Schepp","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.gendis.2019.10.002","article-title":"Recent Advances in Elucidating the Genetics of Common Variable Immunodeficiency","volume":"7","author":"Aggarwal","year":"2019","journal-title":"Genes Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jaci.2014.10.010","article-title":"Hematopoietic Stem Cell Transplantation Rescues the Immunologic Phenotype and Prevents Vasculopathy in Patients With Adenosine Deaminase 2 Deficiency","volume":"135","author":"Van Eyck","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-018-0565-0","article-title":"Warts and DADA2: A Mere Coincidence","volume":"38","author":"Arts","year":"2018","journal-title":"J Clin Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202048549","article-title":"Dysregulation in B-Cell Responses and T Follicular Helper Cell Function in ADA2 Deficiency Patients","volume":"51","author":"Schena","year":"2021","journal-title":"Eur J Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-021-01141-0","article-title":"Intrinsic\u00a0Defects in B Cell Development and Differentiation, T Cell Exhaustion and Altered Unconventional T Cell Generation Characterize Human Adenosine Deaminase Type 2 Deficiency","volume":"41","author":"Yap","year":"2021","journal-title":"J Clin Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-05-717140","article-title":"Pure Red Cell Aplasia","volume":"128","author":"Means","year":"2016","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000947","article-title":"Diamond-Blackfan Anemia","volume":"136","author":"Da Costa","year":"2020","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1056\/NEJMc1405506","article-title":"Mutant\u00a0ADA2 in Vasculopathies","volume":"371","author":"van Montfrans","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev439","article-title":"Phenotypic Variability in Patients With ADA2 Deficiency Due to Identical Homozygous R169Q Mutations","volume":"55","author":"Van Montfrans","year":"2016","journal-title":"Rheumatol (Oxford)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V126.23.3615.3615","article-title":"Adenosine Deaminase 2 Deficiency as a Cause of Pure Red Cell Aplasia Mimicking Diamond Blackfan Anemia","volume":"126","author":"Sasa","year":"2015","journal-title":"Blood"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2016.06.058","article-title":"Extending the Clinical Phenotype of Adenosine Deaminase 2 Deficiency","volume":"177","author":"Ben-Ami","year":"2016","journal-title":"J Pediatr"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-021-01098-0","article-title":"Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients","volume":"41","author":"Hashem","year":"2021","journal-title":"J Clin Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2018.10.027","article-title":"The Genetic Landscape of Diamond-Blackfan Anemia","volume":"103","author":"Ulirsch","year":"2018","journal-title":"Am J Hum Genet"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/j.jaci.2019.12.908","article-title":"Genotype and Functional Correlates of Disease Phenotype in Deficiency of Adenosine Deaminase 2 (DADA2)","volume":"145","author":"Lee","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-07-798660","article-title":"Hematopoietic Stem Cell Transplantation Rescues the Hematological, Immunological, and Vascular Phenotype in DADA2","volume":"130","author":"Hashem","year":"2017","journal-title":"Blood"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1405506","article-title":"Mutant ADA2 in Vasculopathies","volume":"371","author":"Van Eyck","year":"2014","journal-title":"N Engl J Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.181384","article-title":"A Monogenic Disease With a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2","volume":"47","author":"\u00d6zen","year":"2020","journal-title":"J Rheumatol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V130.Suppl_1.874.874","article-title":"Diamond-Blackfan Anemia Phenotype Caused By Deficiency of Adenosine Deaminase 2","volume":"130","author":"Szvetnik","year":"2017","journal-title":"Blood"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15896","article-title":"Novel ADA2 Mutation Presenting With Neutropenia, Lymphopenia and Bone Marrow Failure in Patients With Deficiency in Adenosine Deaminase 2 (DADA2)","volume":"186","author":"Ghurye","year":"2019","journal-title":"Br J Haematol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-018-0487-x","article-title":"Novel Mutation in CECR1 Leads to Deficiency of ADA2 With Associated Neutropenia","volume":"38","author":"Cipe","year":"2018","journal-title":"J Clin Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108443","article-title":"ADA2 Deficiency Complicated by EBV-Driven Lymphoproliferative Disease","volume":"215","author":"Staples","year":"2020","journal-title":"Clin Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12969-019-0334-5","article-title":"Testicular Ischemia in Deficiency of Adenosine Deaminase 2 (DADA2)","volume":"17","author":"Clarke","year":"2019","journal-title":"Pediatr Rheumatol Online J"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.811473","article-title":"The Spectrum of the Deficiency of Adenosine Deaminase 2: An Observational Analysis of a 60 Patient Cohort","volume":"12","author":"Barron","year":"2022","journal-title":"Front Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.748519","article-title":"The Use of Induced Pluripotent Stem Cells to Study the Effects of Adenosine Deaminase Deficiency on Human Neutrophil Development","volume":"12","author":"Tsui","year":"2021","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.754029","article-title":"Case Report: Deficiency of Adenosine Deaminase 2 Presenting With Overlapping Features of Autoimmune Lymphoproliferative Syndrome and Bone Marrow Failure","volume":"12","author":"Dell'Orso","year":"2021","journal-title":"Front Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.15288","article-title":"A Novel Variant of Adenosine Deaminase 2 Deficiency Presented With Chronic Thrombocytopenia, Anemia, and Early-Onset Stroke","volume":"13","author":"Al-Hebshi","year":"2021","journal-title":"Cureus"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1080\/08880018.2019.1621973","article-title":"A Homozygote Novel L451W Mutation in CECR1 Gene Causes Deficiency of Adenosine Deaminase 2 in a Pediatric Patient Representing With Chronic Lymphoproliferation and Cytopenia","volume":"36","author":"Ekinci","year":"2019","journal-title":"Pediatr Hematol Oncol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab011","article-title":"ADA2 Deficiency (DADA2) Associated With Evans Syndrome and a Severe ADA2 Genotype","volume":"60","author":"Ferriani","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1177\/23247096211056770","article-title":"Novel Adenosine Deaminase 2 (ADA2) Mutations Associated With Hematological Manifestations","volume":"9","author":"Albalawi","year":"2021","journal-title":"J Investig Med High Impact Case Rep"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26912","article-title":"Deficiency of ADA2 Mimicking Autoimmune Lymphoproliferative Syndrome in the Absence of Livedo Reticularis and Vasculitis","volume":"65","author":"Alsultan","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-020-00812-8","article-title":"Late-Onset EBV Susceptibility and Refractory Pure Red Cell Aplasia Revealing Dada2","volume":"40","author":"Le Voyer","year":"2020","journal-title":"J Clin Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e29461","DOI":"10.1002\/pbc.29461","article-title":"DADA2 Presenting as Nonimmune Hemolytic Anemia With Recurrent Macrophage Activation Syndrome","author":"Iyengar","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-2266","article-title":"ADA2 Deficiency Mimicking Idiopathic Multicentric Castleman Disease","volume":"142","author":"Van Nieuwenhove","year":"2018","journal-title":"Pediatrics"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02767","article-title":"ALPS-Like Phenotype Caused by ADA2 Deficiency Rescued by Allogeneic Hematopoietic Stem Cell Transplantation","volume":"9","author":"Barzaghi","year":"2019","journal-title":"Front Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2021.09.001","article-title":"DADA2 Diagnosed in Adulthood Versus Childhood: A Comparative Study on 306 Patients Including a Systematic Literature Review and 12 French Cases","volume":"51","author":"Fayand","year":"2021","journal-title":"Semin Arthritis Rheumatol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-019-0590-7","article-title":"Childhood Hodgkin Lymphoma: Think Dada2","volume":"39","author":"Alabbas","year":"2019","journal-title":"J Clin Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01361","article-title":"Deficiency of Adenosine Deaminase 2 in Adult Siblings: Many Years of a Misdiagnosed Disease With Severe Consequences","volume":"9","author":"Springer","year":"2018","journal-title":"Front Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-020-00940-1","article-title":"Uncontrolled Epstein-Barr Virus as an Atypical Presentation of Deficiency in ADA2 (Dada2)","author":"Brooks","year":"2021","journal-title":"J Clin Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"5707","DOI":"10.3390\/molecules26185707","article-title":"A Novel LC\u2013MS\/MS-Based Method for the Diagnosis of ADA2 Deficiency From Dried Plasma Spot","volume":"26","author":"Cafaro","year":"2021","journal-title":"Molecules"},{"key":"B61","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12969-021-00535-z","article-title":"Diagnosis and Management of Adenosine Deaminase 2 Deficiency Children: The Experience From China","volume":"19","author":"Wang","year":"2021","journal-title":"Pediatr Rheumatol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-020-00817-3","article-title":"Deficiency of Adenosine Deaminase 2 (DADA2): Hidden Variants, Reduced Penetrance, and Unusual Inheritance","volume":"40","author":"Schnappauf","year":"2020","journal-title":"J Clin Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000001145","article-title":"Treatment of Two Boys Children Suffering From Deficiency of Adenosine Deaminase Type 2 (DADA2) With TNF-Inhibitor Etanercept","volume":"27","author":"Krutzke","year":"2021","journal-title":"J Clin Rheumatol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00251-018-01101-w","article-title":"A Chinese DADA2 Patient: Report of Two Novel Mutations and Successful HSCT","volume":"71","author":"Liu","year":"2019","journal-title":"Immunogenetics"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-014-2320-8","article-title":"Novel Adenosine Deaminase 2 Mutations in a Child With a Fatal Vasculopathy","volume":"173","author":"Garg","year":"2014","journal-title":"Eur J Pediatr"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-018-0480-4","article-title":"Hematologic Manifestations of Deficiency of Adenosine Deaminase 2 (DADA2) and Response to Tumor Necrosis Factor Inhibition in DADA2-Associated Bone Marrow Failure","volume":"38","author":"Michniacki","year":"2018","journal-title":"J Clin Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000001132","article-title":"\u201cImmune\u201d Thrombocytopenia as Key Feature of a Novel ADA2 Deficiency Variant: Implication on Differential Diagnostics of ITP in Children","volume":"41","author":"Sundin","year":"2019","journal-title":"J Pediatr Hematol Oncol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-05210-4","article-title":"Two Cases of ADA2 Deficiency Presenting as Childhood Polyarteritis Nodosa: Novel ADA2 Variant, Atypical CNS Manifestations, and Literature Review","volume":"39","author":"Ganh\u00e3o","year":"2020","journal-title":"Clin Rheumatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.869570\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T05:48:34Z","timestamp":1651556914000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.869570\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,3]]},"references-count":68,"alternative-id":["10.3389\/fimmu.2022.869570"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.869570","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,3]]},"article-number":"869570"}}